We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCN
276
Waste Connections
WCN
$40.6B
| $50.9M | 0.07% |
305,478
-4,522
| -1% | -$716K |
|
277
Williams Companies
WMB
$91.9B
| $50.6M | 0.07% |
679,999
-39,000
| -5% | -$2.87M |
|
278
Waste Management
WM
$86.5B
| $50.5M | 0.07% |
226,589
-131,860
| -37% | -$29.3M |
|
279
Equitable Holdings
EQH
$14.2B
| $50.5M | 0.07% |
1,150,000
+850,000
| +283% | +$35.5M |
|
280
PACCAR
PCAR
$64.2B
| $50.3M | 0.07% |
419,098
+221,148
| +112% | +$26.1M |
|
281
Rio Tinto
RIO
$169B
| $49.8M | 0.07% |
524,602
| – | – |
|
282
Packaging Corp of America
PKG
$20.3B
| $49.6M | 0.07% |
208,220
-71,480
| -26% | -$15.7M |
|
283
Teledyne Technologies
TDY
$27.6B
| $49.5M | 0.07% |
74,242
-800
| -1% | -$504K |
|
284
Hewlett Packard
HPE
$78.2B
| $49.5M | 0.07% |
1,097,536
+57,100
| +5% | +$2.06M |
|
285
Assurant
AIZ
$13.8B
| $49.4M | 0.07% |
184,140
-160,500
| -47% | -$39.1M |
|
286
Ametek
AME
$54.2B
| $49.4M | 0.07% |
204,241
-2,000
| -1% | -$461K |
|
287
Airbnb
ABNB
$100B
| $49M | 0.07% |
342,500
+212,000
| +162% | +$28.9M |
|
288
Simon Property Group
SPG
$66.2B
| $49M | 0.07% |
219,063
+67,700
| +45% | +$13.9M |
|
289
General Motors
GM
$73.5B
| $48.5M | 0.07% |
628,586
+68,800
| +12% | +$5.41M |
|
290
Charles River Laboratories
CRL
$13.3B
| $48.4M | 0.07% |
213,480
-42,529
| -17% | -$7.57M |
|
291
Hamilton Lane
HLNE
$4.29B
| $48.4M | 0.07% |
613,935
+427,095
| +229% | +$38M |
|
292
Rockwell Automation
ROK
$47.3B
| $47.6M | 0.07% |
96,200
-4,500
| -4% | -$1.96M |
|
293
James Hardie Industries
JHX
$16.8B
| $47.5M | 0.07% |
1,815,375
-1,808,000
| -50% | -$39.7M |
|
|
DFTX
294
Definium Therapeutics
DFTX
$5.1B
| $47M | 0.07% |
1,000,000
-150,000
| -13% | -$3.71M |
|
295
argenx
ARGX
$62.7B
| $47M | 0.07% |
50,607
-39,393
| -44% | -$32.5M |
|
296
Baker Hughes
BKR
$63.2B
| $46.9M | 0.07% |
844,202
+208,900
| +33% | +$13.2M |
|
297
L3Harris
LHX
$46.6B
| $45.7M | 0.06% |
157,309
-10,050
| -6% | -$3.19M |
|
298
Ulta Beauty
ULTA
$23.2B
| $45.5M | 0.06% |
100,852
-75,900
| -43% | -$38.5M |
|
|
BBT
299
Beacon Financial Corp
BBT
$2.6B
| $45.5M | 0.06% |
1,493,023
-332,939
| -18% | -$9.97M |
|
300
Liberty Live Group Series C
LLYVK
$8.92B
| $45.2M | 0.06% |
428,324
+24,717
| +6% | +$2.41M |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.